Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00403408
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
BFB | N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE | A | 2DW5 | 0.77 | |
XXZ | 1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO- 1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]- 4'-AMINE | A,B | 3E65 | 0.7 | |
SP8 | N-{(1S)-3-[(4-aminobutyl)amino]- 1-methylpropyl}benzamide | A,B | 3CNS | 0.72 | |
32U | D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}- L-prolinamide | H,I | 2ZDA | 0.7 | |
FPB | N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN- 2-YL}METHYL)BENZAMIDE | A,B | 2BUB | 0.77 | |
715 | (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)- 5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3- A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN- 2-AMINE | A,B | 1X70 | 0.79 | |
3G3 | 2-[2-(1H-tetrazol-5-yl)ethyl]-1H- isoindole-1,3(2H)-dione | A,B | 3G32 | 0.72 | |
SEI | 1-{3-METHYL-2-[4-(MORPHOLINE-4- CARBONYL)-BENZOYLAMINO]-BUTYRYL}- PYRROLIDINE-2-CARBOXYLIC ACID (3,3,4,4,4- PENTAFLUORO-1-ISOPROPYL-2-OXO-BUTYL)- AMIDE | A | 1B0F | 0.7 | |
SEI | 1-{3-METHYL-2-[4-(MORPHOLINE-4- CARBONYL)-BENZOYLAMINO]-BUTYRYL}- PYRROLIDINE-2-CARBOXYLIC ACID (3,3,4,4,4- PENTAFLUORO-1-ISOPROPYL-2-OXO-BUTYL)- AMIDE | A | 1B0E | 0.7 | |
I19 | N-(4-{[(3S)-3-(dimethylamino)pyrrolidin- 1-yl]carbonyl}phenyl)-5-fluoro- 4-[2-methyl-1-(1-methylethyl)-1H- imidazol-5-yl]pyrimidin-2-amine | A | 2W17 | 0.7 | |
S14 | 6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]- 3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]- 3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5- A]PYRIDIN-4-IUM | A,B | 2FJP | 0.75 | |
37U | D-phenylalanyl-N-(3-fluorobenzyl)- L-prolinamide | H,I | 2ZDV | 0.71 | |
DP7 | AC-(D)PHE-PRO-BOROARG-OH | H | 1LHC | 0.7 | |
448 | (2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)- 5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5- A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5- TRIFLUOROPHENYL)BUTAN-2-AMINE | A,B,S | 2QOE | 0.79 | |
KIQ | (1S,6R)-3-{[3-(TRIFLUOROMETHYL)- 5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3- A]PYRAZIN-7(8H)-YL]CARBONYL}-6- (2,4,5-TRIFLUOROPHENYL)CYCLOHEX- 3-EN-1-AMINE | B | 2I78 | 0.79 | |
24U | 1-butanoyl-N-(4-carbamimidoylbenzyl)- L-prolinamide | H,I | 2ZI2 | 0.7 | |
KR2 | (2R)-4-(2-BENZOYL-1,2-DIAZEPAN- 1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN- 2-AMINE | A,B | 2OLE | 0.71 | |
27U | N-(4-carbamimidoylbenzyl)-1-(3- phenylpropanoyl)-L-prolinamide | H,I | 2ZHQ | 0.7 | |
SP9 | N-{(1R)-3-[(4-aminobutyl)amino]- 1-methylpropyl}benzamide | A,B | 3CNT | 0.72 | |
VX2 | N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3- b]pyridazin-6-amine | A | 3BGQ | 0.7 | |
BAG | N-[(E)-2-AMINO-1-(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)- 2-HYDROXYVINYL]BENZAMIDE | A | 1WDA | 0.7 | |
29U | 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)- L-prolinamide | H,I | 2ZGX | 0.7 |